Show Nav →
Please include the following statement when referencing the CPTAC Assay Portal
We would like to acknowledge the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) Assay Portal (assays.cancer.gov) for developing assays and establishing criteria for the assays described in this publication.

Overview Data source: UniProt

Official Gene Symbol Other Aliases
CCND3 N/A
Sequence Length (AA) Molecular Weight (Da)
292 32520
Protein Name
G1/S-specific cyclin-D3
Sources
UniProt
PhosphoSitePlus ®
GeneCards
Human Protein Atlas

Protein Sequence hover to view complete sequence

10 20 30 40 50
MELLCCEGTR HAPRAGPDPR LLGDQRVLQS LLRLEERYVP RASYFQCVQR
60 70 80 90 100
EIKPHMRKML AYWMLEVCEE QRCEEEVFPL AMNYLDRYLS CVPTRKAQLQ
110 120 130 140 150
LLGAVCMLLA SKLRETTPLT IEKLCIYTDH AVSPRQLRDW EVLVLGKLKW
160 170 180 190 200
DLAAVIAHDF LAFILHRLSL PRDRQALVKK HAQTFLALCA TDYTFAMYPP
210 220 230 240 250
SMIATGSIGA AVQGLGACSM SGDELTELLA GITGTEVDCL RACQEQIEAA
260 270 280 290 292
LRESLREASQ TSSSPAPKAP RGSSSQGPSQ TSTPTDVTAI HL

Data source: UniProt


Position of Targeted Peptide Analytes Relative to SNPs, Isoforms, and PTMs

Uniprot Database Entry PhosphoSitePlus ®

Click a point on a node
to view detailed assay information below
All other points link out to UniProt



Phosphorylation Acetylation Ubiquitylation Other

loading

Loader

Assay Details for CPTAC-2809 Collapse assay details

Data source: Panorama

Official Gene Symbol
CCND3
Peptide Modified Sequence
ASYFQC[+57.0]VQR
Modification Type
Carbamidomethyl (C)
Protein - Site of Modification
47
Peptide - Site of Modification
6
Peptide Start
42
Peptide End
50
CPTAC ID
CPTAC-2809
Peptide Molecular Mass
1,157.5288
Species
Homo Sapiens
Assay Type
Direct PRM
Matrix
Tumor Digest
Submitting Laboratory
Washington University in St. Louis
Submitting Lab PI
Reid Townsend

Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
ThermoFisher, Q-Exactive
Internal Standard
25 fmol on column
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C and 15N at C-terminus R
LC
Easy nLC 1000 Thermo Scientific
Column Packing
C18
Column Dimensions
75 µm x 50 cm
Flow Rate
300 nL/min

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y7 (1+) 14.2 11.2 11.9 14.3 10.4 16 20.2 15.3 19.9 15 15 15
y5 (1+) 13.2 9.8 10.7 14.8 9.7 12 19.8 13.8 16.1 15 15 15
y4 (1+) 10.8 12.1 12 11.9 11.4 13 16.1 16.6 17.7 15 15 15
sum 12.4 10.8 11.2 13.6 10.1 12.5 18.4 14.8 16.8 15 15 15


Additional Resources and Comments


Assay Details for CPTAC-2808 Collapse assay details

Data source: Panorama

Official Gene Symbol
CCND3
Peptide Modified Sequence
LC[+57.0]IYTDHAVSPR
Modification Type
Carbamidomethyl (C)
Protein - Site of Modification
125
Peptide - Site of Modification
2
Peptide Start
124
Peptide End
135
CPTAC ID
CPTAC-2808
Peptide Molecular Mass
1,430.6976
Species
Homo Sapiens
Assay Type
Direct PRM
Matrix
Tumor Digest
Submitting Laboratory
Washington University in St. Louis
Submitting Lab PI
Reid Townsend

Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
ThermoFisher, Q-Exactive
Internal Standard
25 fmol on column
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C and 15N at C-terminus R
LC
Easy nLC 1000 Thermo Scientific
Column Packing
C18
Column Dimensions
75 µm x 50 cm
Flow Rate
300 nL/min

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y5 (1+) 5.3 5.6 6.5 7 7 6.8 8.8 9 9.4 15 15 15
y4 (1+) 9.5 5.2 6.1 10 5.6 6.7 13.8 7.6 9.1 15 15 15
y3 (1+) 6 4.8 7.7 8.6 6.5 8.1 10.5 8.1 11.2 15 15 15
sum 5.1 4.9 6.5 6.9 6.1 6.7 8.6 7.8 9.3 15 15 15


Additional Resources and Comments